Try GOLD - Free
Life and law
Business Standard
|November 01, 2025
From his key judgments to music, cats and veganism, Justice Chandrachud shares snippets of his life with Veenu Sandhu and Bhavini Mishra
As tickler for time, Justice DY Chandrachud is late for our lunch meeting. A visitor has uncharacteristically delayed him, probably thinking that, having retired, the former Chief Justice of India (CJI) would have more time at hand.
He apologises profusely as he meets us at Shang Palace, the fine dining restaurant at the Shangri-La in New Delhi. Impeccably turned out in a crisp shirt, grey trousers, and brown shoes, he appears smaller than his larger-than-life public persona, which earned him descriptors such as “celebrity judge” or “rockstar judge”. Post-retirement, he has published a book, Why the Constitution Matters: Selected Speeches — 34 of them, ranging from gender justice and climate change to art, literature, and the meaning of free speech.
Over the next two-and-a-half hours, over steaming cups of jasmine tea and an elaborate lunch, our conversation traverses between pages and plates, philosophy and food, going from his views about nepotism in judiciary, and poor representation of women in higher courts, to some of his landmark cases and the matter of judges accepting post-retirement positions.
‘The former CJI is vegan. We, too, decide on an all-vegan meal, even though he insists we should eat whatever we please. Veganism for his family, he says, isn't just a diet but a philosophy. “Our daughters — they are special children, extremely ethical — played a big role in the family turning vegan,” he says. Their home is now entirely plant-based, down to coconut milk tea and peanut yogurt. “People often ask how we meet our protein needs,” he smiles. “Our traditional foods — dal, chana, millets — have plenty.” Also, he no longer buys leather products —shoes, belts, ete — and the family makes it a point to return gifts that are not cruelty-free.
This story is from the November 01, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
